首页 > 最新文献

Current Gastroenterology Reports最新文献

英文 中文
Perspectives and Advice from an Interventional Gastroenterologist at a Tertiary Academic Center. 一位三级学术中心介入胃肠病学家的观点和建议。
Q1 Medicine Pub Date : 2024-12-01 Epub Date: 2024-08-20 DOI: 10.1007/s11894-024-00944-6
Salmaan Jawaid

Purpose of the review: The purpose of this review is to detail steps and strategies needed to have success as an interventional gastroenterologist at a tertiary care academic medical center.

Recent findings: Development of a specific niche within interventional endoscopy (IE), can allow an incoming academic interventional endoscopist to make a clinical and academic impact on a regional and national level. As the evolution of IE training continues, the development of a niche will become streamlined, supporting a more efficient academic progression for incoming IE faculty. By showcasing the experience of a junior academic interventional endoscopists, we demonstrate how expansion of a specific clinical interest within interventional endoscopy (IE), in conjunction with a mentoring environment, can facilitate academic and clinical progression at an academic medical center.

综述的目的:本综述的目的是详细介绍在三级医疗学术医疗中心担任介入胃肠病学家取得成功所需的步骤和策略:最近的研究结果:在介入内镜(IE)领域发展一个特定的细分市场,可以让新入职的介入内镜医师在地区和国家层面上产生临床和学术影响。随着介入内镜培训的不断发展,定位的发展将变得更加合理,从而为新入职的介入内镜教师提供更有效的学术发展支持。通过展示一名初级介入内镜医师的经历,我们展示了在介入内镜(IE)领域拓展特定临床兴趣如何与指导环境相结合,从而促进学术医疗中心的学术和临床发展。
{"title":"Perspectives and Advice from an Interventional Gastroenterologist at a Tertiary Academic Center.","authors":"Salmaan Jawaid","doi":"10.1007/s11894-024-00944-6","DOIUrl":"10.1007/s11894-024-00944-6","url":null,"abstract":"<p><strong>Purpose of the review: </strong>The purpose of this review is to detail steps and strategies needed to have success as an interventional gastroenterologist at a tertiary care academic medical center.</p><p><strong>Recent findings: </strong>Development of a specific niche within interventional endoscopy (IE), can allow an incoming academic interventional endoscopist to make a clinical and academic impact on a regional and national level. As the evolution of IE training continues, the development of a niche will become streamlined, supporting a more efficient academic progression for incoming IE faculty. By showcasing the experience of a junior academic interventional endoscopists, we demonstrate how expansion of a specific clinical interest within interventional endoscopy (IE), in conjunction with a mentoring environment, can facilitate academic and clinical progression at an academic medical center.</p>","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"311-314"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142003807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical Media in Pediatric Gastroenterology and Hepatology: Strategies for Effective Use by Consumers, Contributors, and Creators. 儿科胃肠病学和肝病学中的医学媒体:消费者、投稿人和创作者的有效使用策略》。
Q1 Medicine Pub Date : 2024-12-01 Epub Date: 2024-10-17 DOI: 10.1007/s11894-024-00947-3
Temara Hajjat, Paul Tran

Purpose of the review: This review article explores the role of medical media in gastroenterology and hepatology, highlighting its benefits for enhancing clinical practice, education, and patient engagement. It also provides practical guidance for gastroenterologists and hepatologists on effectively implementing these tools in their daily practice.

Recent findings: Recent findings highlight that medical media significantly boosts citation rates and dissemination of research, enhances promotional efforts, and fosters greater engagement from patients and trainees. These advances underscore the growing role of medical media in amplifying academic impact and improving educational outreach in gastroenterology and hepatology. Integrating medical media into pediatric gastroenterology and hepatology offers numerous benefits, from enhanced education and professional development to improved patient engagement. By understanding the roles of contributor, creator, and consumer and leveraging the right platforms and content types, pediatric gastroenterologists and hepatologists can effectively utilize medical media to advance their field and provide better care.

综述的目的:这篇综述文章探讨了医疗媒体在胃肠病学和肝病学中的作用,强调了医疗媒体在加强临床实践、教育和患者参与方面的益处。文章还为胃肠病学和肝病学专家在日常工作中有效使用这些工具提供了实用指导:最近的研究结果表明,医学媒体大大提高了研究的引用率和传播率,加强了宣传工作,并促进了患者和受训人员的更多参与。这些进展凸显了医疗媒体在扩大胃肠病学和肝病学的学术影响和改善教育推广方面日益重要的作用。将医学媒体融入儿科胃肠病学和肝病学可带来诸多益处,从加强教育和专业发展到提高患者参与度,不一而足。通过了解贡献者、创造者和消费者的角色,并利用正确的平台和内容类型,儿科胃肠病学和肝病学专家可以有效地利用医疗媒体来推动其领域的发展并提供更好的医疗服务。
{"title":"Medical Media in Pediatric Gastroenterology and Hepatology: Strategies for Effective Use by Consumers, Contributors, and Creators.","authors":"Temara Hajjat, Paul Tran","doi":"10.1007/s11894-024-00947-3","DOIUrl":"10.1007/s11894-024-00947-3","url":null,"abstract":"<p><strong>Purpose of the review: </strong>This review article explores the role of medical media in gastroenterology and hepatology, highlighting its benefits for enhancing clinical practice, education, and patient engagement. It also provides practical guidance for gastroenterologists and hepatologists on effectively implementing these tools in their daily practice.</p><p><strong>Recent findings: </strong>Recent findings highlight that medical media significantly boosts citation rates and dissemination of research, enhances promotional efforts, and fosters greater engagement from patients and trainees. These advances underscore the growing role of medical media in amplifying academic impact and improving educational outreach in gastroenterology and hepatology. Integrating medical media into pediatric gastroenterology and hepatology offers numerous benefits, from enhanced education and professional development to improved patient engagement. By understanding the roles of contributor, creator, and consumer and leveraging the right platforms and content types, pediatric gastroenterologists and hepatologists can effectively utilize medical media to advance their field and provide better care.</p>","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"349-359"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11496315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142459964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Yoga in Pediatric Gastroenterology. 小儿肠胃病学瑜伽。
Q1 Medicine Pub Date : 2024-12-01 Epub Date: 2024-08-13 DOI: 10.1007/s11894-024-00941-9
Francis Peropat, Mazen I Abbas, Maria E Perez, Elizabeth L Yu, Alycia Leiby

Purpose of review: Pediatric use of yoga as an integrative medicine modality has increased in prevalence over the last several decades. In this article, we review the available evidence for yoga in pediatric gastrointestinal disorders.

Recent findings: Evidence supports that in many pediatric disorders of gut brain interaction (DGBI), including irritable bowel syndrome, functional abdominal pain and functional dyspepsia, yoga decreases pain intensity and frequency and increases school attendance. Yoga has been shown to improve health-related quality of life and improve stress management as an effective adjunct to standard medical therapy in pediatric inflammatory bowel disease (IBD). Further studies are needed regarding optimal frequency, duration of practice and evaluation of the impact on IBD disease activity measures. Yoga may benefit pediatric gastroenterology patients with DGBIs and IBD through improving quality of life and reducing pain. Future yoga studies could investigate biomarkers and continued research will help integrate this modality into routine pediatric gastroenterology care.

综述目的:在过去的几十年中,儿科使用瑜伽作为一种综合医学模式的情况越来越普遍。在本文中,我们回顾了瑜伽治疗小儿胃肠道疾病的现有证据:有证据表明,对于肠易激综合征、功能性腹痛和功能性消化不良等多种小儿肠道脑交互障碍(DGBI),瑜伽可降低疼痛的强度和频率,提高入学率。瑜伽作为小儿炎症性肠病(IBD)标准药物疗法的有效辅助疗法,已被证明能改善与健康相关的生活质量并改善压力管理。关于练习的最佳频率、持续时间以及对 IBD 疾病活动指标影响的评估,还需要进一步研究。瑜伽可通过改善生活质量和减轻疼痛,使患有 DGBIs 和 IBD 的小儿肠胃病患者受益。未来的瑜伽研究可以调查生物标志物,持续的研究将有助于把这种方式纳入常规的儿科胃肠病治疗中。
{"title":"Yoga in Pediatric Gastroenterology.","authors":"Francis Peropat, Mazen I Abbas, Maria E Perez, Elizabeth L Yu, Alycia Leiby","doi":"10.1007/s11894-024-00941-9","DOIUrl":"10.1007/s11894-024-00941-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>Pediatric use of yoga as an integrative medicine modality has increased in prevalence over the last several decades. In this article, we review the available evidence for yoga in pediatric gastrointestinal disorders.</p><p><strong>Recent findings: </strong>Evidence supports that in many pediatric disorders of gut brain interaction (DGBI), including irritable bowel syndrome, functional abdominal pain and functional dyspepsia, yoga decreases pain intensity and frequency and increases school attendance. Yoga has been shown to improve health-related quality of life and improve stress management as an effective adjunct to standard medical therapy in pediatric inflammatory bowel disease (IBD). Further studies are needed regarding optimal frequency, duration of practice and evaluation of the impact on IBD disease activity measures. Yoga may benefit pediatric gastroenterology patients with DGBIs and IBD through improving quality of life and reducing pain. Future yoga studies could investigate biomarkers and continued research will help integrate this modality into routine pediatric gastroenterology care.</p>","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"335-341"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11496368/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments. 钾竞争性胃酸阻滞剂:当前的临床应用和未来发展。
Q1 Medicine Pub Date : 2024-11-01 Epub Date: 2024-08-15 DOI: 10.1007/s11894-024-00939-3
Carmelo Scarpignato, Richard H Hunt

Purpose of the review: Acid suppression with proton pump inhibitors (PPIs) represents the standard of care in the treatment of acid-related diseases. However, despite their effectiveness, PPIs display some intrinsic limitations, which underlie the unmet clinical needs that have been identified over the past decades. The aims of this review are to summarize the current status and future development of the new class of antisecretory drugs (potassium-competitive acid blockers, P-CABs) that have recently been introduced into medical practice.

Recent findings: Over the past decades, clinical needs unmet by the current acid suppressants have been recognized, especially in the management of patients with GERD, Helicobacter pylori infection and NSAID-related peptic ulcer. The failure to address these needs is mainly due to their inability to achieve a consistent acid suppression in all patients and, particularly, to control nighttime acidity. It was then realized that an extended duration of acid suppression would exert additional benefits. The available data with P-CABs show that they are able to address these unmet clinical needs. Four different P-CABs (vonoprazan, tegoprazan, fexuprazan and keverprazan) are currently available. However, only two of them are approved outside Asia. Vonoprazan is available in North, Central and South America while tegoprazan is marketed only in Latin American countries. Two other compounds (namely linazapran glurate and zestaprazan) are presently under clinical development. While clinical trials on GERD have been performed with all P-CABs, only vonoprazan and tegoprazan have been investigated as components of Helicobacter pylori eradication regimens. The available data show that-in the above two clinical indications-P-CABs provide similar or better efficacy in comparison with PPIs. Their safety in the short-term overlaps that of PPIs, but data from long-term treatment are needed.

综述的目的:使用质子泵抑制剂(PPIs)抑制胃酸是治疗胃酸相关疾病的标准疗法。然而,尽管质子泵抑制剂很有效,但其本身也存在一些局限性,这也是过去几十年来临床需求未得到满足的原因。本综述旨在总结最近引入医疗实践的新型抗分泌药物(钾竞争性胃酸阻滞剂,P-CABs)的现状和未来发展:在过去的几十年中,人们已经认识到目前的抑酸药物无法满足临床需求,尤其是在治疗胃食管反流病、幽门螺杆菌感染和非甾体抗炎药相关消化性溃疡患者方面。无法满足这些需求的主要原因是,它们无法对所有患者实现持续的抑酸效果,尤其是无法控制夜间酸度。后来人们意识到,延长抑酸时间会带来更多益处。P-CABs 的现有数据表明,它们能够满足这些尚未满足的临床需求。目前市场上有四种不同的 P-CABs(vonoprazan、tegoprazan、fexuprazan 和 keverprazan)。然而,其中只有两种在亚洲以外地区获得批准。Vonoprazan 在北美洲、中美洲和南美洲有售,而 tegoprazan 仅在拉丁美洲国家销售。另外两种化合物(即胶酸利纳唑仑和zestaprazan)目前正在临床开发中。虽然对所有 P-CABs 都进行了胃食管反流病的临床试验,但只有 vonoprazan 和 tegoprazan 作为根除幽门螺旋杆菌疗法的成分进行了研究。现有数据显示,在上述两种临床适应症中,P-CABs 的疗效与 PPIs 相似或更好。其短期安全性与 PPIs 相同,但还需要长期治疗的数据。
{"title":"Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments.","authors":"Carmelo Scarpignato, Richard H Hunt","doi":"10.1007/s11894-024-00939-3","DOIUrl":"10.1007/s11894-024-00939-3","url":null,"abstract":"<p><strong>Purpose of the review: </strong>Acid suppression with proton pump inhibitors (PPIs) represents the standard of care in the treatment of acid-related diseases. However, despite their effectiveness, PPIs display some intrinsic limitations, which underlie the unmet clinical needs that have been identified over the past decades. The aims of this review are to summarize the current status and future development of the new class of antisecretory drugs (potassium-competitive acid blockers, P-CABs) that have recently been introduced into medical practice.</p><p><strong>Recent findings: </strong>Over the past decades, clinical needs unmet by the current acid suppressants have been recognized, especially in the management of patients with GERD, Helicobacter pylori infection and NSAID-related peptic ulcer. The failure to address these needs is mainly due to their inability to achieve a consistent acid suppression in all patients and, particularly, to control nighttime acidity. It was then realized that an extended duration of acid suppression would exert additional benefits. The available data with P-CABs show that they are able to address these unmet clinical needs. Four different P-CABs (vonoprazan, tegoprazan, fexuprazan and keverprazan) are currently available. However, only two of them are approved outside Asia. Vonoprazan is available in North, Central and South America while tegoprazan is marketed only in Latin American countries. Two other compounds (namely linazapran glurate and zestaprazan) are presently under clinical development. While clinical trials on GERD have been performed with all P-CABs, only vonoprazan and tegoprazan have been investigated as components of Helicobacter pylori eradication regimens. The available data show that-in the above two clinical indications-P-CABs provide similar or better efficacy in comparison with PPIs. Their safety in the short-term overlaps that of PPIs, but data from long-term treatment are needed.</p>","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"273-293"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11401795/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141981934","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Virtual Reality in the Management of Irritable Bowel Syndrome. 虚拟现实技术在肠易激综合征治疗中的作用。
Q1 Medicine Pub Date : 2024-11-01 Epub Date: 2024-08-13 DOI: 10.1007/s11894-024-00940-w
Karisma K Suchak, Christopher V Almario, Omer Liran, Robert Chernoff, Brennan R Spiegel

Purpose of review: Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction that significantly impacts health-related quality of life (HRQOL). This article explores the potential role of virtual reality (VR)-based cognitive behavioral therapy (CBT) in treating patients with IBS.

Recent findings: While CBT is a proven, skills-based therapy approach that modifies behaviors and alters dysfunctional thinking patterns to influence the gut-brain axis and improve IBS symptoms, it is rarely prescribed given a paucity of CBT-trained clinicians. We developed a novel VR program that delivers a standardized CBT program over an 8-week period to help patients manage their symptoms. In initial qualitative validation testing, patients expressed positive perceptions about using VR CBT for IBS. Home-based, standardized VR CBT has the potential to be an effective and scalable treatment option for patients with IBS. While initial studies have shown proof-of-concept definitive randomized controlled trials are needed to demonstrate the efficacy of self-administered VR CBT in IBS.

综述的目的:肠易激综合征(IBS)是一种肠道与大脑相互作用的疾病,严重影响与健康相关的生活质量(HRQOL)。本文探讨了基于虚拟现实(VR)的认知行为疗法(CBT)在治疗肠易激综合征患者中的潜在作用:虽然 CBT 是一种行之有效的、以技能为基础的治疗方法,它能改变行为,改变功能失调的思维模式,从而影响肠道-大脑轴,改善肠易激综合征症状,但由于受过 CBT 培训的临床医生很少,因此很少有人采用这种方法。我们开发了一种新颖的 VR 程序,在 8 周内提供标准化的 CBT 程序,帮助患者控制症状。在最初的定性验证测试中,患者对使用 VR CBT 治疗肠易激综合征表达了积极的看法。基于家庭的标准化 VR CBT 有可能成为肠易激综合征患者有效且可扩展的治疗方案。虽然初步研究已经证明了这一概念,但要证明自控式 VR CBT 对肠易激综合征的疗效,还需要进行明确的随机对照试验。
{"title":"The Role of Virtual Reality in the Management of Irritable Bowel Syndrome.","authors":"Karisma K Suchak, Christopher V Almario, Omer Liran, Robert Chernoff, Brennan R Spiegel","doi":"10.1007/s11894-024-00940-w","DOIUrl":"10.1007/s11894-024-00940-w","url":null,"abstract":"<p><strong>Purpose of review: </strong>Irritable bowel syndrome (IBS) is a disorder of gut-brain interaction that significantly impacts health-related quality of life (HRQOL). This article explores the potential role of virtual reality (VR)-based cognitive behavioral therapy (CBT) in treating patients with IBS.</p><p><strong>Recent findings: </strong>While CBT is a proven, skills-based therapy approach that modifies behaviors and alters dysfunctional thinking patterns to influence the gut-brain axis and improve IBS symptoms, it is rarely prescribed given a paucity of CBT-trained clinicians. We developed a novel VR program that delivers a standardized CBT program over an 8-week period to help patients manage their symptoms. In initial qualitative validation testing, patients expressed positive perceptions about using VR CBT for IBS. Home-based, standardized VR CBT has the potential to be an effective and scalable treatment option for patients with IBS. While initial studies have shown proof-of-concept definitive randomized controlled trials are needed to demonstrate the efficacy of self-administered VR CBT in IBS.</p>","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"294-303"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11401788/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current and Emerging Applications of Artificial Intelligence (AI) in the Management of Pancreatobiliary (PB) disorders. 人工智能 (AI) 在胰胆管 (PB) 疾病管理中的当前和新兴应用。
Q1 Medicine Pub Date : 2024-11-01 Epub Date: 2024-08-12 DOI: 10.1007/s11894-024-00942-8
Nikhil Bush, Mouen Khashab, Venkata S Akshintala

PURPOSE OF REVIEW: In this review, we aim to summarize the existing literature and future directions on the use of artificial intelligence (AI) for the diagnosis and treatment of PB (pancreaticobiliary) disorders. RECENT FINDINGS: AI models have been developed to aid in the diagnosis and management of PB disorders such as pancreatic adenocarcinoma (PDAC), pancreatic neuroendocrine tumors (pNETs), acute pancreatitis, chronic pancreatitis, autoimmune pancreatitis, choledocholithiasis, indeterminate biliary strictures, cholangiocarcinoma and endoscopic procedures such as ERCP, EUS, and cholangioscopy. Recent studies have integrated radiological, endoscopic and pathological data to develop models to aid in better detection and prognostication of these disorders. AI is an indispensable proponent in the future practice of medicine. It has been extensively studied and approved for use in the detection of colonic polyps. AI models based on clinical, laboratory, and radiomics have been developed to aid in the diagnosis and management of various PB disorders and its application is ever expanding. Despite promising results, these AI-based models need further external validation to be clinically applicable.

综述目的:在这篇综述中,我们旨在总结有关使用人工智能(AI)诊断和治疗胰胆管疾病的现有文献和未来方向。最新发现:人工智能模型已被开发用于辅助诊断和治疗胰胆管疾病,如胰腺腺癌(PDAC)、胰腺神经内分泌肿瘤(pNETs)、急性胰腺炎、慢性胰腺炎、自身免疫性胰腺炎、胆总管结石、不确定胆道狭窄、胆管癌以及ERCP、EUS和胆道镜等内镜手术。最近的研究将放射学、内窥镜和病理学数据整合在一起,开发出有助于更好地检测和预后这些疾病的模型。人工智能是未来医学实践中不可或缺的支持者。它已被广泛研究并批准用于检测结肠息肉。基于临床、实验室和放射组学的人工智能模型已被开发出来,以帮助诊断和管理各种肺结核疾病,其应用范围正在不断扩大。尽管取得了可喜的成果,但这些基于人工智能的模型还需要进一步的外部验证才能应用于临床。
{"title":"Current and Emerging Applications of Artificial Intelligence (AI) in the Management of Pancreatobiliary (PB) disorders.","authors":"Nikhil Bush, Mouen Khashab, Venkata S Akshintala","doi":"10.1007/s11894-024-00942-8","DOIUrl":"10.1007/s11894-024-00942-8","url":null,"abstract":"<p><p>PURPOSE OF REVIEW: In this review, we aim to summarize the existing literature and future directions on the use of artificial intelligence (AI) for the diagnosis and treatment of PB (pancreaticobiliary) disorders. RECENT FINDINGS: AI models have been developed to aid in the diagnosis and management of PB disorders such as pancreatic adenocarcinoma (PDAC), pancreatic neuroendocrine tumors (pNETs), acute pancreatitis, chronic pancreatitis, autoimmune pancreatitis, choledocholithiasis, indeterminate biliary strictures, cholangiocarcinoma and endoscopic procedures such as ERCP, EUS, and cholangioscopy. Recent studies have integrated radiological, endoscopic and pathological data to develop models to aid in better detection and prognostication of these disorders. AI is an indispensable proponent in the future practice of medicine. It has been extensively studied and approved for use in the detection of colonic polyps. AI models based on clinical, laboratory, and radiomics have been developed to aid in the diagnosis and management of various PB disorders and its application is ever expanding. Despite promising results, these AI-based models need further external validation to be clinically applicable.</p>","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"304-309"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141970755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Clinician's Guide To Effectively Transitioning and Transferring Care For Pediatric Patients With Inflammatory Bowel Diseases From The Pediatric To Adult Gastroenterologist. 儿科胃肠病医生向成人胃肠病医生有效过渡和移交儿科炎症性肠病患者护理的临床医生指南》。
Q1 Medicine Pub Date : 2024-10-01 Epub Date: 2024-07-16 DOI: 10.1007/s11894-024-00936-6
Jessica N Barry, Jonathan D Moses, Sandra C Kim

Purpose of review: Transition of care for pediatric patients with inflammatory bowel diseases (IBD) is a continuous, dynamic process that takes place over several years with a coordinated approach executed by a multidisciplinary team. We review the concepts, tools, and research in effective transitioning and transfer of care for adolescent/young adult patients with IBD.

Recent findings: Given the constraints within the healthcare system, effective transitioning can be challenging to implement in everyday clinical practice. Different barriers include resources and expertise in effective transitioning by pediatric and adult gastroenterology healthcare providers and the impact of non-gastrointestinal issues facing young adult patients who are learning to manage and coordinate all aspects of their medical care and health maintenance. Factors that facilitate successful care transitioning and transfer include structured transitioning programs, utilization of validated transition checklists, and IBD medical summaries. Proactive transitioning by pediatric gastroenterologists in partnership with their emerging young adult patients with IBD leads to better clinical and psychosocial outcomes and ultimately, effective transfer of care to adult gastroenterology. By utilizing utilize comprehensive transition assessment tools and medical summaries in partnership with their patients, pediatric and adult gastroenterology teams can better prepare patients as they transfer to independent care and health maintenance.

审查目的:儿科炎症性肠病(IBD)患者的护理转归是一个持续、动态的过程,需要多学科团队协调合作,历时数年。我们回顾了青少年/年轻成人 IBD 患者护理有效过渡和转移的概念、工具和研究:鉴于医疗保健系统内部的限制,在日常临床实践中实施有效的转归可能具有挑战性。不同的障碍包括:儿科和成人消化科医疗服务提供者在有效过渡方面的资源和专业知识,以及正在学习管理和协调医疗保健和健康维护各个方面的年轻成人患者所面临的非胃肠道问题的影响。促进医疗过渡和转院成功的因素包括结构化的过渡计划、使用有效的过渡清单和 IBD 医疗摘要。儿科胃肠病医生与新出现的年轻成年 IBD 患者合作,积极主动地进行过渡,可获得更好的临床和社会心理疗效,并最终有效地将医疗服务转至成人胃肠病科。通过与患者合作利用综合过渡评估工具和医疗总结,儿科和成人肠胃病团队可以为患者转入独立护理和健康维护做好更好的准备。
{"title":"A Clinician's Guide To Effectively Transitioning and Transferring Care For Pediatric Patients With Inflammatory Bowel Diseases From The Pediatric To Adult Gastroenterologist.","authors":"Jessica N Barry, Jonathan D Moses, Sandra C Kim","doi":"10.1007/s11894-024-00936-6","DOIUrl":"10.1007/s11894-024-00936-6","url":null,"abstract":"<p><strong>Purpose of review: </strong>Transition of care for pediatric patients with inflammatory bowel diseases (IBD) is a continuous, dynamic process that takes place over several years with a coordinated approach executed by a multidisciplinary team. We review the concepts, tools, and research in effective transitioning and transfer of care for adolescent/young adult patients with IBD.</p><p><strong>Recent findings: </strong>Given the constraints within the healthcare system, effective transitioning can be challenging to implement in everyday clinical practice. Different barriers include resources and expertise in effective transitioning by pediatric and adult gastroenterology healthcare providers and the impact of non-gastrointestinal issues facing young adult patients who are learning to manage and coordinate all aspects of their medical care and health maintenance. Factors that facilitate successful care transitioning and transfer include structured transitioning programs, utilization of validated transition checklists, and IBD medical summaries. Proactive transitioning by pediatric gastroenterologists in partnership with their emerging young adult patients with IBD leads to better clinical and psychosocial outcomes and ultimately, effective transfer of care to adult gastroenterology. By utilizing utilize comprehensive transition assessment tools and medical summaries in partnership with their patients, pediatric and adult gastroenterology teams can better prepare patients as they transfer to independent care and health maintenance.</p>","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"255-262"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11387428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141619590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positioning Crohn's Disease Therapies in the Era of Small Molecules and Combination Therapies. 在小分子和联合疗法时代定位克罗恩病疗法。
Q1 Medicine Pub Date : 2024-10-01 Epub Date: 2024-07-06 DOI: 10.1007/s11894-024-00937-5
Ariela K Holmer, David Hudesman
{"title":"Positioning Crohn's Disease Therapies in the Era of Small Molecules and Combination Therapies.","authors":"Ariela K Holmer, David Hudesman","doi":"10.1007/s11894-024-00937-5","DOIUrl":"10.1007/s11894-024-00937-5","url":null,"abstract":"","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"263-272"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141544681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Esophageal Per-Oral Endoscopic Myotomy (E-POEM): Future Directions and Perspectives. 食道口腔内窥镜肌切开术(E-POEM):未来方向与展望。
Q1 Medicine Pub Date : 2024-10-01 Epub Date: 2024-08-08 DOI: 10.1007/s11894-024-00938-4
William W King, Dennis Yang, Peter V Draganov

Purpose of review: POEM is a mature procedure endorsed by societal guidelines as a first line therapy for achalasia and spastic esophageal disorders. Nonetheless, several questions remain, including expanding indications for POEM, periprocedural evaluation and management, and the optimal POEM technique to enhance clinical success while mitigating risk for reflux.

Recent findings: There is uncertainty regarding several technical aspects of the POEM myotomy; though aggregating evidence supports the use of real-time impedance planimetry to guide the myotomy. While post-POEM reflux remains a concerning long term sequela, there is an increasing focus on the potential role of endoscopic anti-reflux interventions. Lastly, with the widespread adoption of POEM, we continue to witness ongoing efforts to standardize post-procedural care and training in this procedure. POEM is no longer a novel but rather established procedure. Yet, this technique has continued to evolve, with the aim of optimizing treatment success while reducing adverse events and risk for post-procedural reflux.

审查目的:贲门失弛缓术(POEM)是一种成熟的手术,已被社会指南认可为治疗贲门失弛缓症和痉挛性食管疾病的一线疗法。然而,仍存在一些问题,包括 POEM 适应症的扩大、围手术期的评估和管理,以及提高临床成功率同时降低反流风险的最佳 POEM 技术:最近的研究结果:POEM 肌切开术的几个技术方面还存在不确定性;但有综合证据支持使用实时阻抗平面测量法指导肌切开术。虽然 POEM 术后反流仍是一个令人担忧的长期后遗症,但人们越来越关注内窥镜抗反流干预措施的潜在作用。最后,随着 POEM 的广泛应用,我们将继续努力实现术后护理和培训的标准化。POEM 已不再是一种新手术,而是一种成熟的手术。然而,这项技术仍在不断发展,目的是优化治疗的成功率,同时减少不良事件和术后反流的风险。
{"title":"Esophageal Per-Oral Endoscopic Myotomy (E-POEM): Future Directions and Perspectives.","authors":"William W King, Dennis Yang, Peter V Draganov","doi":"10.1007/s11894-024-00938-4","DOIUrl":"10.1007/s11894-024-00938-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>POEM is a mature procedure endorsed by societal guidelines as a first line therapy for achalasia and spastic esophageal disorders. Nonetheless, several questions remain, including expanding indications for POEM, periprocedural evaluation and management, and the optimal POEM technique to enhance clinical success while mitigating risk for reflux.</p><p><strong>Recent findings: </strong>There is uncertainty regarding several technical aspects of the POEM myotomy; though aggregating evidence supports the use of real-time impedance planimetry to guide the myotomy. While post-POEM reflux remains a concerning long term sequela, there is an increasing focus on the potential role of endoscopic anti-reflux interventions. Lastly, with the widespread adoption of POEM, we continue to witness ongoing efforts to standardize post-procedural care and training in this procedure. POEM is no longer a novel but rather established procedure. Yet, this technique has continued to evolve, with the aim of optimizing treatment success while reducing adverse events and risk for post-procedural reflux.</p>","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"241-250"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141906170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tips and Thought Processes to Overcome Difficult Situations in Third Space Endoscopy. 在第三空间内窥镜检查中克服困难情况的技巧和思维过程。
Q1 Medicine Pub Date : 2024-10-01 Epub Date: 2024-05-14 DOI: 10.1007/s11894-024-00935-7
Amit Maydeo, Nagesh Kamat, Gaurav Patil, Ankit Dalal, Amol Vadgaonkar, Sanil Parekh

Purpose of review: Third space endoscopy (TSE) offers diverse treatment options for a variety of conditions of the gastrointestinal tract and motility disorders. Accuracy and precise dissection have helped treat complex conventional surgeries with TSE. Despite over a decade of its presence, difficult situations are routinely encountered.

Recent findings: The first challenging situation is decision-making (before the procedure), the second is tackling procedure-induced pulmonary / insufflation-related adverse events and intra-operative complications (during the procedure), and the third is post-operative complications and morbidity (post-procedure). The performance of TSE procedures is not without risk. Patients should receive enough time to weigh their options, considering that attitudes toward risk impact decision-making. Continuous basic patient monitoring and the micro-movements of endoscopic and electrosurgical equipment is crucial to avoid accidental injury. Anaesthetists should be mindful of anticipated complications and closely monitor, diagnose, and treat them. Demanding situations need careful consideration, problem-solving, or persistence to overcome challenges. This brief review provides inputs on preventing and tackling difficult situations in TSE.

审查目的:第三空间内窥镜(TSE)为各种胃肠道疾病和运动障碍提供了多种治疗方案。TSE 的准确性和精确解剖有助于治疗复杂的传统手术。尽管 TSE 已经存在了十多年,但仍经常遇到困难情况:第一个难题是决策(手术前),第二个难题是解决手术引起的肺部/充气相关不良事件和术中并发症(手术中),第三个难题是术后并发症和发病率(手术后)。进行 TSE 手术并非没有风险。考虑到对风险的态度会影响决策,患者应有足够的时间权衡自己的选择。对患者进行持续的基本监测以及内窥镜和电外科设备的微小移动对避免意外伤害至关重要。麻醉师应注意预期的并发症,并对其进行密切监测、诊断和治疗。在要求苛刻的情况下,需要仔细考虑、解决问题或坚持不懈地克服挑战。这篇简短的评论为预防和处理 TSE 中的困难情况提供了参考。
{"title":"Tips and Thought Processes to Overcome Difficult Situations in Third Space Endoscopy.","authors":"Amit Maydeo, Nagesh Kamat, Gaurav Patil, Ankit Dalal, Amol Vadgaonkar, Sanil Parekh","doi":"10.1007/s11894-024-00935-7","DOIUrl":"10.1007/s11894-024-00935-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>Third space endoscopy (TSE) offers diverse treatment options for a variety of conditions of the gastrointestinal tract and motility disorders. Accuracy and precise dissection have helped treat complex conventional surgeries with TSE. Despite over a decade of its presence, difficult situations are routinely encountered.</p><p><strong>Recent findings: </strong>The first challenging situation is decision-making (before the procedure), the second is tackling procedure-induced pulmonary / insufflation-related adverse events and intra-operative complications (during the procedure), and the third is post-operative complications and morbidity (post-procedure). The performance of TSE procedures is not without risk. Patients should receive enough time to weigh their options, considering that attitudes toward risk impact decision-making. Continuous basic patient monitoring and the micro-movements of endoscopic and electrosurgical equipment is crucial to avoid accidental injury. Anaesthetists should be mindful of anticipated complications and closely monitor, diagnose, and treat them. Demanding situations need careful consideration, problem-solving, or persistence to overcome challenges. This brief review provides inputs on preventing and tackling difficult situations in TSE.</p>","PeriodicalId":10776,"journal":{"name":"Current Gastroenterology Reports","volume":" ","pages":"251-254"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140921624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Gastroenterology Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1